Sensei Biotherapeutics seeks stockholder vote on preferred conversion triggering control change

Filed May 21, 2026 · Period ending May 21, 2026 · ~1 min read

Key Changes

• high

  Company will ask stockholders on June 10 to approve converting Series B Preferred Stock into common shares, which will issue over 20% of outstanding stock and trigger a change of control under Nasdaq rules.

  Item 8.01 verify on EDGAR →
• medium

  Filed pro forma financials for Q1 2026 showing what the balance sheet would look like after the preferred stock conversion, helping investors understand the dilution impact before voting.

  Item 9.01 verify on EDGAR →
• low

  Annual stockholder meeting scheduled for June 10, 2026 at 11:00 a.m. EDT where the conversion vote and other matters will be decided.

  Item 8.01 verify on EDGAR →